Overview

Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)

Status:
Completed
Trial end date:
2018-08-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine T-cell mediated inflammatory immune response in some participants previously exposed to atabecestat.
Phase:
Early Phase 1
Details
Lead Sponsor:
Janssen Research & Development, LLC